Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Blood Advances|September 26, 2019
Comparison of characteristics and outcomes of late acute and NIH chronic GVHD between Japanese and white patientsYoshihiro Inamoto, Jennifer White, Reiko Ito, et al.
International Journal of Hematology|March 25, 2025
Oral beclomethasone dipropionate therapy and prognostic plasma biomarkers for gastrointestinal graft-versus-host diseaseYoshihiro Inamoto, Ayumu Ito, Toshihisa Nakashima, et al.
American Journal of Hematology|January 2, 2024
Association of individual comorbidities with outcomes in allogeneic hematopoietic cell transplantation from unrelated adult donors versus unrelated cord blood: A study on behalf of the Donor/Source and Transplant Complications Working Groups of the Japanese Society for Transplantation and Cellular TherapyTakaaki Konuma, Kaito Harada, Akihito Shinohara, et al.
European Journal of Haematology|January 21, 2025
Increased Non-Relapse Mortality in Older People With Allogeneic Hematopoietic Stem Cell Transplantation Using Fludarabine and Myeloablative Dose of Busulfan-Based RegimenAkihito Shinohara, Michiho Shindo, Nobuaki Nakano, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 18, 2017
Double-Expressor Lymphoma Is Associated with Poor Outcomes after Allogeneic Hematopoietic Cell TransplantationIchiro Kawashima, Yoshihiro Inamoto, Akiko Miyagi Maeshima, et al.
International Journal of Hematology|January 4, 2021
Effect of donor type on volume of blood transfusions required after allogeneic hematopoietic cell transplantationSaiko Kurosawa, Takuhiro Yamaguchi, Saori Nakabayashi, et al.
Transplantation and Cellular Therapy|March 17, 2025
Fludarabine Plus Myeloablative Dose of Busulfan Regimen Was Associated with High Nonrelapse Mortality in Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Lymphoma: A Propensity Score-Matched Comparison Study with Fludarabine Plus High-Dose MelphalanAkihito Shinohara, Michiho Shindo, Satoshi Yamasaki, et al.
Annals of Hematology|January 15, 2022
Prognostic implication of CTLA-4, PD-1, and PD-L1 expression in aggressive adult T-cell leukemia-lymphomaAkio Onishi, Shigeo Fuji, Shigehisa Kitano, et al.
Cytotherapy|November 6, 2024
Outcome of donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation in relapsed myelodysplastic syndromeAtsushi Marumo, Yasunobu Nagata, Machiko Fujioka, et al.
Transplantation and Cellular Therapy|August 30, 2025
Allogeneic hematopoietic stem cell transplantation for older patients with adult T-cell leukemia/lymphoma: A nationwide retrospective studyHikaru Sakamoto, Yasushi Sawayama, Shigeo Fuji, et al.
Pageof 10